Last reviewed · How we verify

NCT05400863

Effect of NNS on Metformin/GDF15, Pilot

Completed NA Last updated 5 August 2024
What this trial tests

NA trial testing avoid sugary and NNS drinks plus start Metformin in Obesity, Adolescent in 46 participants. Completed in 2 August 2024.

Timeline
21 April 2022
Primary endpoint
2 August 2024
2 August 2024

Quick facts

Lead sponsorUniversity of Florida
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment46
Start date21 April 2022
Primary completion2 August 2024
Estimated completion2 August 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Florida

Who can join

Adults 10 to 21, any sex, with Obesity, Adolescent or Pre Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Metformin use for diabetes has the benefit of causing weight loss in some. The investigators in a preclinical trial, demonstrated that mice consuming non-nutritive sweetened (NNS) drinks had worse glucose improvements and weight loss than mice consuming sugar drinks or water. This study will conduct a pilot to determine if this translates into pediatric clinical practice. The hypothesis is that NNS drinks impair metformin-induced satiation, weight loss, and glucose tolerance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Obesity, Adolescent

Currently open trials in the same condition.

Other University of Florida trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05400863.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing